Literature DB >> 26618423

Randomized Controlled Trial of Transoral Incisionless Fundoplication Vs. Proton Pump Inhibitors for Treatment of Gastroesophageal Reflux Disease.

Reginald C W Bell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26618423     DOI： 10.1038/ajg.2015.324

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.

Authors:  Bart P L Witteman; Jose M Conchillo; Nicolaas F Rinsma; Bark Betzel; Andrea Peeters; Ger H Koek; Laurents P S Stassen; Nicole D Bouvy
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

2.  Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.

Authors:  John G Hunter; Peter J Kahrilas; Reginald C W Bell; Erik B Wilson; Karim S Trad; James P Dolan; Kyle A Perry; Brant K Oelschlager; Nathaniel J Soper; Brad E Snyder; Miguel A Burch; William Scott Melvin; Kevin M Reavis; Daniel G Turgeon; Eric S Hungness; Brian S Diggs
Journal:  Gastroenterology       Date:  2014-10-13       Impact factor: 22.682

3.  Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).

Authors:  David Milkes; Lauren B Gerson; George Triadafilopoulos
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

4.  Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations.

Authors:  Reginald C W Bell; Guy-Bernard Cadière
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

5.  Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study.

Authors:  Karim Sami Trad; Gilbert Simoni; William Edris Barnes; Ahmad Bassel Shughoury; Mamoon Raza; Jeffrey Alan Heise; Daniel Gilles Turgeon; Mark Alan Fox; Peter George Mavrelis
Journal:  BMC Gastroenterol       Date:  2014-10-06       Impact factor: 3.067
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.